Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by rgonlyfactsplson Apr 22, 2015 11:45am
238 Views
Post# 23652728

Who is Clarus? Oh yeah...

Who is Clarus? Oh yeah......I do recall back to Sept. 2014 with not so good memories. The institutional support is now overwhelming (goal discussed at AGM). Dear Telesta management.... Thank you for thinking of shareholders. --- BELLEVILLE, ON, September 23, 2014 – Bioniche Life Sciences Inc.......has closed its previously announced equity offering (the "Offering") of 25,070,000 units (the "Units") priced at $0.23 per Unit for total proceeds of $5,766,100, including the over-allotment option, which was fully exercised by the Agents (as defined below) concurrently with the completion of the Offering. Each Unit consists of one common share (a "Common Share") and one-half of a warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.30 for a period of 60 months from the date hereof. The Units were issued pursuant to an agency agreement between the Company and Dundee Securities Ltd., as lead agent, Clarus Securities Inc. and Euro Pacific Canada Inc
<< Previous
Bullboard Posts
Next >>